Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

328.35 +7.34 (+2.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Amgen

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
41 42 Next >
Buffett Is Buying
Warren Buffett has recently put the cash pile at Berkshire to work, buying stock and entire companies. So what exactly is Buffett buying and why? 
Via Talk Markets
Dividend Income Update March 2022
The start of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. 
Via Talk Markets
$1000 Invested In Amgen 10 Years Ago Would Be Worth This Much
Amgen (NASDAQ:AMGN) has outperformed the market over the past 10 years by 1.13% on an annualized basis producing an average annual return of 13.98%. Currently, Amgen has a market capitalization of... 
Via Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
As these Chinese stocks face delisting, some may provide a contrarian play on improving relations between the U.S. and China. 
Via InvestorPlace
Looking Into Amgen Inc's Recent Short Interest
Amgen Inc's (NASDAQ:AMGN) short percent of float has risen 123.83% since its last report. The company recently reported that it has 26.62 million shares sold short, which is 4.79... 
Via Benzinga
Ten Healthcare Companies With High Payout Ratio
The healthcare industry is among the biggest U.S. market segments in terms of market capitalization, but when it comes to dividend payouts, they rank very low. 
Via Talk Markets
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much
Amgen (NASDAQ:AMGN) has outperformed the market over the past 10 years by 1.42% on an annualized basis. Buying $100 In AMGN: 10 years ago, an investor could have purchased 1.47... 
Via Benzinga
Best Biotech Stocks To Buy In 2022
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and... 
Via Talk Markets
The Dow Curse
It has been 386 trading days since the last Dow changes were made at the end of August 2020. Below we show how the stocks added and removed performed in the 386 trading days leading up to the index... 
Via Talk Markets
Markets Fall Again As Russia-Ukraine War Erodes Investor Sentiment
U.S. Indices finished lower Friday amid continued uncertainty from the Russia-Ukraine conflict. The Nasdaq composite finished lower by 2.18% to 12,843; The Invesco QQQ Trust... 
Via Benzinga
Truist Sees 350% Upside On This Cancer-Focused Biopharma Stock - Read Why
Truist has initiated coverage on Verastem Oncology Inc (NASDAQ: VSTM) with a Buy rating and $6.00 price target, equivalent to approximately 350% upside. Analyst... 
Via Benzinga
7 Dividend Stocks to Finance Your Golden Years
If you're a long-term investor you need top-quality dividend stocks in your portfolio. That doesn't mean big yields as much as reliable ones. 
Via InvestorPlace
AbbVie, Alvotech Resolve US Patent Dispute Related To Humira Biosimilar
Alvotech Holdings S.A. has entered into a settlement agreement with AbbVie Inc (NYSE: ABBV), allowing Alvotech to market AVT02 (100 mg/mL), its high-... 
Via Benzinga
Can-Fite BioPharma Flags Delay In Piclidenoson Data Readout From Psoriasis Study
Citing unanticipated delay in the collection of study data, Can-Fite BioPharma Ltd (NYSE: CANF) said that the topline data from its Phase 3 Comfort study of Piclidenoson... 
Via Benzinga
Markets Close Lower Again In Up And Down Trading Day; Nasdaq Falls 1.5%
U.S. indices had a mixed day of trading, with stocks experiencing continued volatility amid the Russia-Ukraine conflict. The conflict has continued... 
Via Benzinga
36 Stocks To Watch After Biden's First State of The Union Address
President Joe Biden hosted his first State of the Union Address Tuesday in front of members of Congress. In the speech, Biden discussed several items that he has already helped... 
Via Benzinga
Amgen's Tezspire Reduces Annualized Exacerbation Rate In Severe Asthma Patients
Amgen Inc (NASDAQ: AMGN) shared results from a pooled post-hoc analysis of the NAVIGATOR Phase 3 and PATHWAY Phase 2b trials of Tezspire (tezepelumab-ekko) in broad... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
A Bullish Sign Appears On Amgen's Chart
If history is any guide, there may be good fortune ahead for shares of Amgen (NASDAQ:AMGN). A so-called "golden cross" has formed on its chart and, not surprisingly, this could... 
Via Benzinga
Apple And Nike Lead The Dow Jones Lower Amid Russia-Ukraine Tensions
U.S. indices traded lower Tuesday after Russia ordered troops into separatist regions of Ukraine after recognizing the Donetsk and Luhansk regions ... 
Via Benzinga
"Prudent" Biotech Bets
Here, we review two recommended biotechnology stocks following the release of their latest earnings reports. Let's take a look. 
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them?
Can the formerly red-hot biotech segment return to its previous glory? 
Via Investor's Business Daily
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following... 
Via Benzinga
Amgen Posts Latest Batch of Lumakras Data In Pancreatic Cancer
Amgen Inc (NASDAQ: AMGN) announced the presentation of efficacy and safety data from the CodeBreaK 100 Phase 1/2 trial in KRAS G12C-mutated advanced... 
Via Benzinga
Large Cap Biopharma- Well Positioned For Choppy Markets
If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets. 
Via Talk Markets
7 Defensive Growth Stocks to Buy for February
These seven top defensive growth stocks are among the best options for investors looking for growth, but with a risk-off perspective. 
Via InvestorPlace
This Is What Whales Are Betting On Amgen
Someone with a lot of money to spend has taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
41 42 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.